Cerner Enviza Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Cerner Enviza's estimated annual revenue is currently $126.4M per year.(i)
  • Cerner Enviza's estimated revenue per employee is $142,800

Employee Data

  • Cerner Enviza has 885 Employees.(i)
  • Cerner Enviza grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.6M32-30%N/AN/A
#2
$24.2M21647%N/AN/A
#3
$2.9M36-8%N/AN/A
#4
$65.7M5158%N/AN/A
#5
$2.9M360%N/AN/A
#6
$8.7M8520%N/AN/A
#7
$10.7M105-29%N/AN/A
#8
$8.8M8625%N/AN/A
#9
$0.3M5-17%N/AN/A
#10
$1.9M2618%N/AN/A
Add Company

Cerner Enviza aims to accelerate the discovery, development and delivery of extraordinary insights and therapies to improve everyday health for all people globally. By combining decades of innovation, life sciences knowledge and collaborative research, Cerner Enviza provides data-driven solutions and expertise that helps bring remarkable clarity to healthcare’s most important decisions. For more information on Cerner Enviza, visit www.cernerenviza.com

keywords:N/A

N/A

Total Funding

885

Number of Employees

$126.4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cerner Enviza News

2022-04-20 - THE INTERNATIONAL GAUCHER ALLIANCE AND CERNER ...

THE INTERNATIONAL GAUCHER ALLIANCE AND CERNER ENVIZA ENROLL FIRST PATIENT IN GARDIAN REGISTRY. Cerner (PRNewsfoto/Cerner Corp.) News provided by.

2022-04-20 - 2022-04-26 | NDAQ:CERN | Press Release | Cerner Corporation

THE INTERNATIONAL GAUCHER ALLIANCE AND CERNER ENVIZA ENROLL FIRST PATIENT IN GARDIAN REGISTRY. CERN | 6 hours ago. KANSAS CITY, Mo., April 26,...

2022-04-20 - THE INTERNATIONAL GAUCHER ALLIANCE AND CERNER ENVIZA ENROLL FIRST PATIENT IN GARDIAN REGISTRY

THE INTERNATIONAL GAUCHER ALLIANCE AND CERNER ENVIZA ENROLL FIRST PATIENT IN GARDIAN REGISTRY. Link copied. 04/26/2022 | 09:21am...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$288.1M9088%N/A
#2
$395M9734%N/A
#3
$221.5M98933%N/A
#4
$35M101722%N/A
#5
$894M103318%N/A